Genetic factors for overweight and CAD

Herz

Volumn 31, Issue 3, 2006, Pages 189-199

  Brönner, Günter ^a   Erdmann, Jeanette ^b   Mayer, Björn ^b   Hinney, Anke ^a   Hebebrand, Johannes ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

CAD; Genetics; Obesity

Indexed keywords

ADIPOCYTE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMORBIDITY; CORONARY ARTERY DISEASE; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EVALUATION; EXTENDED FAMILY; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; GENETICS; GENOME; HEART INFARCTION; HEREDITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; RECEPTOR GENE; RISK FACTOR; SIBLING; TRIACYLGLYCEROL BLOOD LEVEL;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS; LINKAGE (GENETICS); OBESITY; PREVALENCE;

EID: 33745122556     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2797-7     Document Type: Article

References (100)

1. Taubes G. As obesity rates rise, experts struggle to explain why. Science 1998;280:1367-8.
2. Neel JV, Weder AB, Julius S. Type II diabetes,essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med 1998;42:44-74.
3. Hebebrand J, Friedel S, Schauble N, et al. Perspectives: molecular genetic research in human obesity. Obes Rev 2003;4:139-46.
4. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950;41:317-8.
5. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 1966;153:1127-8.
6. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973;9:294-8.
7. Chua SC Jr, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996;271:994-6.
8. Tartaglia LA, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71.
9. Zhang Y, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
10. Montague CT, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
11. Strobel A, Issad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-5.
12. Farooqi IS, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-84.
13. Farooqi IS, et al. Partial leptin deficiency and human adiposity. Nature 2001;414:34-5.
14. Licinio J, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004;101:4531-6.
15. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992;71:1195-204.
16. Miller MW, et al. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 1993;7:454-67.
17. Naggert JK, et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995;10:135-42.
18. Huszar D, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-41.
19. Yaswen L, Diehl N, Brennan MB, et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999;5:1066-70.
20. Ollmann MM, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997;278:135-8.
21. Hinney A, et al. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003;88:4258-67.
22. Giesen K, Plum L, Kluge R, et al. Diet-dependent obesity and hypercholesterolemia in the New Zealand obese mouse: identification of a quantitative trait locus for elevated serum cholesterol on the distal mouse chromosome 5. Biochem Biophys Res Commun 2003;304:812-7.
23. Ortlepp JR, et al. A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse. Eur J Clin Invest 2000;30:195-202.
24. Perusse L, et al. The human obesity gene map: the 2004 update. Obes Res 2005;13:381-490.
25. Snyder EE, et al. The human obesity gene map: the 2003 update. Obes Res 2004;12:369-439.
26. Hinney A, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999;84:1483-6.
27. Vaisse C, Clement K, Guy-Grand B, et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998;20:113-4.
28. Yeo GS, et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998;20:111-2.
29. Noben-Trauth K, Naggert JK, North MA, et al. A candidate gene for the mouse mutation tubby. Nature 1996;380:534-8.
30. Kleyn PW, et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996;85:281-90.
31. Chen Y, Duhl DM, Barsh GS. Opposite orientations of an inverted duplication and allelic variation at the mouse agouti locus. Genetics 1996;144:265-77.
32. Clement K, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
33. Jackson RS, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997;16:303-6.
34. Boutin P, et al. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol 2003;1:E68.
35. Swarbrick MM, et al. Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol 2005;3:e315.
36. Herbert A, et al. A common genetic variant 10 kb upstream of INSIG2 is associated with adult and childhood obesity. Science 2006:312:279-83.
37. Farooqi IS, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093-103.
38. Williamson DA, et al. Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite 2005;45:75-80.
39. Matochik JA, et al. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab 2005;90:2851-4.
40. Haskell-Luevano C, Monck EK. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 2001;99:1-7.
41. Nijenhuis WA, Oosterom J, Adan RA. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 2001;15:164-71.
42. Reizes O, et al. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 2001;106:105-16.
43. Cai G, et al. Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22. Am J Clin Nutr 2004;80:1410-4.
44. Comuzzie AG, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997;15:273-6.
45. Hixson JE, et al. Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab 1999;84:3187-91.
46. Krude H, et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-7.
47. Krude H, et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003;88:4633-40.
48. Challis BG, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002;11:1997-2004.
49. Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 2005;239:1-14.
50. Dempfle A, et al. Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet 2004;41:795-800.
51. Young EH, et al. The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29,563 individuals. submitted.
52. Geller F, et al. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 2004;74:572-81.
53. Heid IM, et al. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 2005;42:e21.
54. Bronner G, et al.The 103I variant of the melanocortin 4 receptor (MC4R) is associated with low serum triglyceride levels. J Clin Endocrinol Metab 2006;91:535-8.
55. Tunstall-Pedoe H, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700.
56. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-8.
57. Samani NJ. Molecular genetics of coronary artery disease: measuring the phenotype. Clin Sci (Lond) 1998;95:645-6.
58. Fischer M, et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005;111:855-62.
59. Gretarsdottir S, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003;35:131-8.
60. Boer JM, Feskens EJ, Verschuren WM, et al. The joint impact of family history of myocardial infarction and other risk factors on 12-year coronary heart disease mortality. Epidemiology 1999;10:767-70.
61. Hawe E, Talmud PJ, Miller GJ, et al. Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Ann Hum Genet 2003;67:97-106.
62. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-6.
63. Watkins H, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995;11:434-7.
64. Garg V, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-4.
65. Charron P, et al. Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case. Prenat Diagn 2004;24:701-3.
66. Cambien F, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
67. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology 2003;54:59-71.
68. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-90.
69. Chiappelli M, et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005;32:349-53.
70. Bennet AM, et al. Association of TNF-[alpha] serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006:in press.
71. Holloway JW, Yang IA, Ye S. Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet Genom 2005;15:15-21.
72. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-32.
73. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004;5:89-100.
74. Thomas DC, Haile RW, Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet 2005;77:337-45.
75. Ozaki K, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-4.
76. Yamada A, et al. Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 2004;82:477-83.
77. Koch W, Tiroch K, Beckerath N von, et al. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 2003;24:161-71.
78. Procardis Consortium. A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur J Hum Genet 2004;12:770-4.
79. Pajukanta P, et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000;67:1481-93.
80. Francke S, et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001;10:2751-65.
81. Broeckel U, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002;30:210-4.
82. Harrap SB, et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 2002;22:874-8.
83. Wang Q, et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 2004;74:262-71.
84. Hauser ER, et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD study. Am J Hum Genet 2004;75:436-47.
85. Helgadottir A, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004;36:233-9.
86. Kaaman M, et al. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance. Int J Obes (Lond) 2005;30:447-52.
87. Wang L, Fan C, Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003;302:1578-81.
88. Gonzalez P, et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet 2005;43:167-9.
89. Weng L, et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest 2005;115:1016-20.
90. Bhagavatula MR, et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 2004;13:3181-8.
91. Stoll M, et al. New target regions for human hypertension via comparative genomics. Genome Res 2000;10:473-82.
92. Korstanje R, DiPetrillo K. Unraveling the genetics of chronic kidney disease using animal models. Am J Physiol Renal Physiol 2004;287:F347-52.
93. Paigen B, Morrow A, Brandon C, et al. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985;57:65-73.
94. Wang X, Ishimori N, Korstanje R, et al. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 2005;77:1-15.
95. Wang X, Korstanje R, Higgins D, et al. Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res 2004;14:1767-72.
96. Paigen B, Mitchell D, Holmes PA, et al. Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice. Biochem Genet 1987;25:881-92.
97. Paigen B, Albee D, Holmes PA, et al. Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem. Genet. 1987;25:501-11.
98. Paigen B, et al. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci U S A 1987;84:3763-7.
99. Phelan SA, Beier DR, Higgins DC, et al. Confirmation and high resolution mapping of an atherosclerosis susceptibility gene in mice on chromosome 1. Mamm Genome 2002;13:548-53.
100. Wang X, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 2005;37:365-72.